Evaluation of Etanercept for Treatment of Reactive Infectious Mucocutaneous Eruption.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33439235.
- Also identified by DOI 10.1001/jamadermatol.2020.5166 and PMC identifier 7807388.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study evaluates the association of etanercept treatment with outcomes of reactive infectious mucocutaneous eruption in hospitalized children and adolescents.
Medical subject headings
- Erythema Multiforme
- Etanercept
- Immunosuppressive Agents